Form 3 Arteris, Inc. For: Oct 26 Filed by: Chitkara Raman
- Wall Street closes higher with Nasdaq boosted by tech rally
- Apple (AAPL) Gets a New Street High Price Target, Morgan Stanley Says iPhone Supply and App Store Could Fuel December Quarter Beat
- 'No Rival to Get Even Close' - Tesla (TSLA) Shares Soar as UBS Raises Price Target by Nearly 40%
- Intel (INTC) Shares Surge on Plans to Take Mobileye Public, Morgan Stanley Says Move a Significant Positive
- Digital World Acquisition Corp. (DWAC) Stock Jumps As U.S. Congressman Nunes Leaves to Head Trump Media
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
2. Date of Event Requiring Statement
3. Issuer Name
Ticker or Trading Symbol
Arteris, Inc. [ AIP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
5. If Amendment, Date of Original Filed
6. Individual or Joint/Group Filing (Check
|Table I - Non-Derivative Securities Beneficially Owned|
|1. Title of Security (Instr. 4)||2. Amount of Securities Beneficially Owned (Instr. 4)||3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)||4. Nature of Indirect Beneficial Ownership (Instr. 5)|
|Common Stock||66,000 (1)|
Table II - Derivative Securities Beneficially Owned|
(e.g., puts, calls, warrants, options, convertible securities)
|1. Title of Derivative Security (Instr. 4)||2. Date Exercisable and Expiration Date (Month/Day/Year)||3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)||4. Conversion or Exercise Price of Derivative Security||5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)||6. Nature of Indirect Beneficial Ownership (Instr. 5)|
|Date Exercisable||Expiration Date||Title||Amount or Number of Shares|
|/s/ Paul Alpern as Attorney-in-fact for Raman K. Chitkara||10/26/2021|
|** Signature of Reporting Person||Date|
|Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.|
|* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).|
|** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).|
|Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.|
|Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.|
POWER OF ATTORNEY
With respect to holdings of and transactions in securities issued by Arteris, Inc. (the “Company”), the undersigned hereby constitutes and appoints the individuals named on Schedule A attached hereto and as may be amended from time to time, or any of them signing singly, with full power of substitution and resubstitution, to act as the undersigned’s true and lawful attorney-in-fact to:
prepare, execute in the undersigned’s name and on the undersigned’s behalf, and submit to the United States Securities and Exchange Commission (the “SEC”) a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain and/or regenerate codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC;
execute for and on behalf of the undersigned, Forms 3, 4, and 5 in accordance with Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder;
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and resubstitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12th day of October 2021.
Signature: _/s/ Raman K. Chitkara_______
Print Name: Raman K. Chitkara
Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and Resubstitution
Nicholas B. Hawkins
Paul L. Alpern
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sampo plc signs agreement to acquire full ownership in Hastings
- MRM Health Announces First Patient Dosed with Next Generation Live Microbiome Consortia Therapeutic MH002 in Phase 1b/2a Study in Patients with Ulcerative Colitis
- SalMar – Scottish Sea Farms Ltd. acquisition of Grieg Seafood Hjaltland UK Ltd. cleared by all relevant competition authorities
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!